Breaking News
Get 45% Off 0
🤖 Are you in? These 5 AI-picked stocks are up 15%+
Read article

Editor`s Picks

Contribute
Geoff Considine, Ph.D
Despite Some Concerns, AbbVie Stock Is Still Worth A Look By Geoff Considine, Ph.D - Feb 16, 2022

ABBV faces a significant loss of revenue beginning in 2023 from Humira biosimilars For now, the company is turning in steady earnings growth Wall Street consensus outlook is bullish, but with only 3%...

Continue with Apple
Continue with Google
or
Sign up with Email